Balchem Q2 net sales $284M (+11.2% YoY); record quarterly earnings; credit facility expanded to $650M

BALCHEM CORP

Net sales $284.0M (+11.2% YoY); GAAP EPS $1.39 vs $1.17; adjusted EPS $1.49 vs $1.27.
Record quarterly net earnings $44.6M (+16.6%) and adjusted EBITDA $77.9M (+12.6%).
Credit agreement amended: borrowing capacity increased to $650M, maturity extended to July 24, 2031.
Repurchased $29M of stock in Q2, $114M over trailing twelve months.
All three reporting segments delivered sales and earnings growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.